Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03002922 · ClinicalTrials.gov registry record · NA

Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)

A NA study of Sunscreening Agents, sponsored by Bayer.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT03002922 is a NA study of Sunscreening Agents that has completed, run by Bayer. The registered enrollment target is 17 participants, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03002922, a NA study of Sunscreening Agents, has completed, sponsored by Bayer.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after exercise compared to the full coverage observed prior to exercise

Conditions Studied

Interventions

  • DRUG BAY987517

Study Locations (1)

Florida

  • Hill Top Research - St. Petersburg

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2017-01-18
Est. Completion 2017-01-28
Phase NA

Sponsor

Bayer

591 total trials

What the Registry Record Tells You About NCT03002922

The ClinicalTrials.gov registry entry for NCT03002922 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (79% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 1 intervention - of which BAY987517 is the first listed.

NCT03002922 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03002922 about?

NCT03002922 is a clinical study titled "Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)". To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after exercise compared to the full coverage observed prior to exercise

What is the current status of trial NCT03002922?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2017-01-18. Estimated completion is 2017-01-28.

What conditions does trial NCT03002922 study?

This clinical trial studies the following conditions: Sunscreening Agents.

What interventions are being tested in trial NCT03002922?

The interventions under investigation include: BAY987517 (DRUG).

Who is sponsoring clinical trial NCT03002922?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03002922 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sunscreening Agents

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.